Related references
Note: Only part of the references are listed.Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia
Alexander O. Pasternak et al.
AIDS (2010)
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+T lymphocytes
Laetitia Redel et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications
Victor G. Valcour et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Comparison of real-time PCR methods for measurement of HIV-1 proviral DNA
G. Rozera et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR
Makiko Kondo et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations
Gabriella Rozera et al.
RETROVIROLOGY (2009)
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naive to antiretrovirals
Carlo Torti et al.
CURRENT HIV RESEARCH (2008)
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens
Emanuele Nicastri et al.
CURRENT HIV RESEARCH (2008)
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro
Kersten K. Koelsch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: Levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy
J. M. Carr et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
Giulia Marchetti et al.
AIDS (2006)
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy:: Association of immune activation, T cell maturation markers, and cellular HIV-1 DNA
Miguel Goicoechea et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy
L Sarmati et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts
C Rouzioux et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler® real-time PCR -: art. no. 15
B Kabamba-Mukadi et al.
BMC INFECTIOUS DISEASES (2005)
New estimation method for highly sensitive quantitation of human immunodeficiency virus type 1 DNA and its application
H Nagai et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level
JP Viard et al.
AIDS (2004)
Delayed HIV-1 infection of CD4(+) T lymphocytes from therapy-naive patients demonstrated by quantification of HIV-1 DNA copy numbers
K Wada et al.
MICROBIOLOGY AND IMMUNOLOGY (2004)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children
A Saitoh et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy
E Riva et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy
N Ngo-Giang-Huong et al.
AIDS (2001)
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment
M Burgard et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
Cellular proviral HIV-DNA decline and viral isolation in naive subjects with <5000 copies/ml of HIV-RNA and >500 x 106/I CD4 cells treated with highly active antiretroviral therapy
A Andreoni et al.
AIDS (2000)
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timing of antiretroviral therapy
T Schacker et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
